Women Facing Fertility Complications from Cancer Treatment

In honor of National Ovarian Cancer Month and Gynecologic Cancer Month, both taking place in September, Walgreens and Ferring Pharmaceuticals Inc. has announced a collaboration to provide free access to certain fertility medications and educational resources as part of Ferring's h.e.a.r.t. BEAT program. The program is a patient assistance initiative funded by Ferring and provided as a public service to eligible women of reproductive age who have received a new cancer diagnosis and wish to undergo fertility preservation prior to the start of their cancer treatment.

The h.e.a.r.t. BEAT program will provide certain fertility medications to eligible patients enrolled in the program. It will also provide educational resources through Walgreens Specialty Pharmacy, such as access to highly specialized nurses, informational guides detailing how cancer treatment affects fertility, multimedia materials outlining potential fertility options patients may wish to discuss with their physician, and specialized modules to teach injection training.